TABLE 4.
OR (95% CI) | p value | |
---|---|---|
ACE2 (rs2285666) | ||
CC vs. TT (Recessive-1) | 10.83 (5.36–20.71) | <0.001 |
CC + CT vs. TT (Recessive-2) | 10.15 (5.34–19.30) | <0.001 |
CC vs. CT + TT (Dominant) | 5.01 (3.18–7.89) | <0.001 |
CC vs CT (Co–dominant) | 1.68 (0.89–3.19) | 0.108 |
CT vs. CC + TT (over dominant) | 0.94 (0.50–1.76) | 0.848 |
TMPRSS2 (rs12329760) | ||
CC vs. TT (Recessive-1) | 5.03 (1.40–18.14) | 0.007 |
CC + CT vs. TT (Recessive-2) | 4.21 (1.17–15.13) | 0.017 |
CC vs. CT + TT (Dominant) | 3.30 (1.97–5.52) | <0.001 |
CC vs CT (Co–dominant) | 3.05 (1.76–5.29) | <0.001 |
CT vs. CC + TT (over dominant) | 0.35 (0.20–0.60) | <0.001 |
Genotype on the left is the reference.
OR, Odds ratio; CI 95%, Confidence interval at 95%; ACE2, Angiotensin-converting enzyme 2; TMPRSS2, Transmembrane serine protease 2; C, cytosine; T, thymine.